Your browser doesn't support javascript.
loading
Which magnetic resonance imaging feature is associated with treatment response in perianal fistulizing Crohn's disease?
Richard, Nicolas; Derinck, Antonin; Bridoux, Valérie; Charpentier, Cloé; Savoye Collet, Céline; Savoye, Guillaume.
Afiliação
  • Richard N; Department of Gastroenterology, CHU Rouen, INSERM, ADEN UMR1073, Nutrition, Inflammation and microbiota-gut-brain axis, Univ Rouen Normandie, 76000, Rouen, France. nicolas.richard1@etu.univ-rouen.fr.
  • Derinck A; Department of Radiology, CHU Rouen, 76000, Rouen, France.
  • Bridoux V; Department of Digestive Surgery, CHU Rouen, 76000, Rouen, France.
  • Charpentier C; Department of Gastroenterology, CHU Rouen, 76000, Rouen, France.
  • Savoye Collet C; Department of Radiology, CHU Rouen, QUANTIF-LITIS EA 4108, Univ Rouen Normandie, 76000, Rouen, France.
  • Savoye G; Department of Gastroenterology, CHU Rouen, INSERM, ADEN UMR1073, Nutrition, Inflammation and microbiota-gut-brain axis, Univ Rouen Normandie, 76000, Rouen, France.
Abdom Radiol (NY) ; 2024 Mar 21.
Article em En | MEDLINE | ID: mdl-38512515
ABSTRACT

PURPOSE:

Perianal fistulae are disabling complications of Crohn's Disease. Magnetic resonance imaging features could predict treatment response. This study aimed to determine which magnetic resonance imaging features were predictive of long-term clinical outcome in real life.

METHODS:

Consecutive patients with magnetic resonance imaging performed in a tertiary center were retrospectively analyzed. Clinical outcome was defined as a need for surgical drainage of perianal fistulae or hospitalization. Clinical data and magnetic resonance imaging features (MAGNIFI-CD and Van Assche indices, degree of fibrosis) were studied.

RESULTS:

Fifty-two patients were included between 2016 and 2019 with a mean follow-up of 38 months [29;48]. A higher MAGNIFI-CD index (17/25 versus 11/25; p < 0.01) was associated with an unfavorable long-term clinical outcome. The MAGNIFI-CD index showed an area under the curve of 0.74 (p = 0.006) to predict the clinical outcome of perianal Crohn's disease, compared to 0.67 (p < 0.05) for the Van Assche index. At a threshold of 13 for the MAGNIFI-CD index, sensitivity was 75% (CI95% [59%; 86%]) and specificity was 69% (CI95% [44%; 86%]). No association was found between the degree of fibrosis and clinical outcome, but the association of a high degree of fibrosis (≥ 80%) and of a low MAGNIFI-CD index (≤ 13) was predictive of clinical outcome (p < 0.01).

CONCLUSION:

The MAGNIFI-CD index could be used to predict clinical outcome in perianal Crohn's disease. In combination with a high degree of fibrosis, a low MAGNIFI-CD index, may help to identify patients with the best prognosis.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Abdom Radiol (NY) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Abdom Radiol (NY) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França